FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2503937174> ?p ?o ?g. }

• W2503937174 endingPage "4792" @default.
• W2503937174 startingPage "4786" @default.
• W2503937174 abstract "ABSTRACT Our study aims to identify the clinical breakpoints (CBPs) of second-line drugs (SLDs) above which standard therapy fails in order to improve multidrug-resistant tuberculosis (MDR-TB) treatment. MICs of SLDs were determined for M. tuberculosis isolates cultured from 207 MDR-TB patients in a prospective cohort study in China between January 2010 and December 2012. Classification and regression tree (CART) analysis was used to identify the CBPs predictive of treatment outcome. Of the 207 MDR-TB isolates included in the present study, the proportion of isolates above the critical concentration recommended by WHO ranged from 5.3% in pyrazinamide to 62.8% in amikacin. By selecting pyrazinamide as the primary node (CBP, 18.75 mg/liter), 72.1% of sputum culture conversions at month four could be predicted. As for treatment outcome, pyrazinamide (CBP, 37.5 mg/liter) was selected as the primary node to predict 89% of the treatment success, followed by ofloxacin (CBP, 3 mg/liter), improving the predictive capacity of the primary node by 10.6%. Adjusted by identified confounders, the CART-derived pyrazinamide CBP remained the strongest predictor in the model of treatment outcome. Our findings indicate that the critical breakpoints of some second-line drugs and PZA need to be reconsidered in order to better indicate MDR-TB treatment outcome." @default.
• W2503937174 created "2016-08-23" @default.
• W2503937174 creator A5007224795 @default.
• W2503937174 creator A5028072443 @default.
• W2503937174 creator A5028667300 @default.
• W2503937174 creator A5031491320 @default.
• W2503937174 creator A5036151138 @default.
• W2503937174 creator A5072929017 @default.
• W2503937174 creator A5081061481 @default.
• W2503937174 creator A5085060070 @default.
• W2503937174 date "2016-08-01" @default.
• W2503937174 modified "2023-10-16" @default.
• W2503937174 title "Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China" @default.
• W2503937174 cites W1698129006 @default.
• W2503937174 cites W179084545 @default.
• W2503937174 cites W188186552 @default.
• W2503937174 cites W1969100590 @default.
• W2503937174 cites W1976845701 @default.
• W2503937174 cites W1998568814 @default.
• W2503937174 cites W2029728996 @default.
• W2503937174 cites W2036317207 @default.
• W2503937174 cites W2042369892 @default.
• W2503937174 cites W2043625807 @default.
• W2503937174 cites W2060188978 @default.
• W2503937174 cites W2066938608 @default.
• W2503937174 cites W2072641903 @default.
• W2503937174 cites W2082445705 @default.
• W2503937174 cites W2097133372 @default.
• W2503937174 cites W2104750364 @default.
• W2503937174 cites W2106163016 @default.
• W2503937174 cites W2107834145 @default.
• W2503937174 cites W2130403968 @default.
• W2503937174 cites W2132793435 @default.
• W2503937174 cites W2141869299 @default.
• W2503937174 cites W2145441337 @default.
• W2503937174 cites W2154149749 @default.
• W2503937174 cites W2157031637 @default.
• W2503937174 cites W2166113903 @default.
• W2503937174 cites W2199941204 @default.
• W2503937174 cites W2249116031 @default.
• W2503937174 cites W55019144 @default.
• W2503937174 doi "https://doi.org/10.1128/aac.03008-15" @default.
• W2503937174 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4958164" @default.
• W2503937174 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27246779" @default.
• W2503937174 hasPublicationYear "2016" @default.
• W2503937174 type Work @default.
• W2503937174 sameAs 2503937174 @default.
• W2503937174 citedByCount "21" @default.
• W2503937174 countsByYear W25039371742017 @default.
• W2503937174 countsByYear W25039371742018 @default.
• W2503937174 countsByYear W25039371742019 @default.
• W2503937174 countsByYear W25039371742021 @default.
• W2503937174 countsByYear W25039371742022 @default.
• W2503937174 countsByYear W25039371742023 @default.
• W2503937174 crossrefType "journal-article" @default.
• W2503937174 hasAuthorship W2503937174A5007224795 @default.
• W2503937174 hasAuthorship W2503937174A5028072443 @default.
• W2503937174 hasAuthorship W2503937174A5028667300 @default.
• W2503937174 hasAuthorship W2503937174A5031491320 @default.
• W2503937174 hasAuthorship W2503937174A5036151138 @default.
• W2503937174 hasAuthorship W2503937174A5072929017 @default.
• W2503937174 hasAuthorship W2503937174A5081061481 @default.
• W2503937174 hasAuthorship W2503937174A5085060070 @default.
• W2503937174 hasBestOaLocation W25039371741 @default.
• W2503937174 hasConcept C126322002 @default.
• W2503937174 hasConcept C142724271 @default.
• W2503937174 hasConcept C176674119 @default.
• W2503937174 hasConcept C2776301714 @default.
• W2503937174 hasConcept C2777107064 @default.
• W2503937174 hasConcept C2777975735 @default.
• W2503937174 hasConcept C2778607973 @default.
• W2503937174 hasConcept C2780459521 @default.
• W2503937174 hasConcept C2781069245 @default.
• W2503937174 hasConcept C71924100 @default.
• W2503937174 hasConceptScore W2503937174C126322002 @default.
• W2503937174 hasConceptScore W2503937174C142724271 @default.
• W2503937174 hasConceptScore W2503937174C176674119 @default.
• W2503937174 hasConceptScore W2503937174C2776301714 @default.
• W2503937174 hasConceptScore W2503937174C2777107064 @default.
• W2503937174 hasConceptScore W2503937174C2777975735 @default.
• W2503937174 hasConceptScore W2503937174C2778607973 @default.
• W2503937174 hasConceptScore W2503937174C2780459521 @default.
• W2503937174 hasConceptScore W2503937174C2781069245 @default.
• W2503937174 hasConceptScore W2503937174C71924100 @default.
• W2503937174 hasFunder F4320321001 @default.
• W2503937174 hasIssue "8" @default.
• W2503937174 hasLocation W25039371741 @default.
• W2503937174 hasLocation W25039371742 @default.
• W2503937174 hasLocation W25039371743 @default.
• W2503937174 hasLocation W25039371744 @default.
• W2503937174 hasOpenAccess W2503937174 @default.
• W2503937174 hasPrimaryLocation W25039371741 @default.
• W2503937174 hasRelatedWork W1964825709 @default.
• W2503937174 hasRelatedWork W2390045243 @default.
• W2503937174 hasRelatedWork W2407467694 @default.
• W2503937174 hasRelatedWork W2502833441 @default.
• W2503937174 hasRelatedWork W2584595883 @default.
• W2503937174 hasRelatedWork W2744335668 @default.

• next